Browse > Article
http://dx.doi.org/10.3347/kjp.2013.51.1.69

The Route of Leishmania tropica Infection Determines Disease Outcome and Protection against Leishmania major in BALB/c Mice  

Mahmoudzadeh-Niknam, Hamid (Department of Immunology, Pasteur Institute of Iran)
Khalili, Ghader (Department of Immunology, Pasteur Institute of Iran)
Abrishami, Firoozeh (Department of Immunology, Pasteur Institute of Iran)
Najafy, Ali (Department of Immunology, Pasteur Institute of Iran)
Khaze, Vahid (Department of Immunology, Pasteur Institute of Iran)
Publication Information
Parasites, Hosts and Diseases / v.51, no.1, 2013 , pp. 69-74 More about this Journal
Abstract
Leishmania tropica is one of the causative agents of leishmaniasis in humans. Routes of infection have been reported to be an important variable for some species of Leishmania parasites. The role of this variable is not clear for L. tropica infection. The aim of this study was to explore the effects of route of L. tropica infection on the disease outcome and immunologic parameters in BALB/c mice. Two routes were used; subcutaneous in the footpad and intradermal in the ear. Mice were challenged by Leishmani major, after establishment of the L. tropica infection, to evaluate the level of protective immunity. Immune responses were assayed at week 1 and week 4 after challenge. The subcutaneous route in the footpad in comparison to the intradermal route in the ear induced significantly more protective immunity against L. major challenge, including higher delayed-type hypersensitivity responses, more rapid lesion resolution, lower parasite loads, and lower levels of IL-10. Our data showed that the route of infection in BALB/c model of L. tropica infection is an important variable and should be considered in developing an appropriate experimental model for L. tropica infections.
Keywords
Leishmania tropica; Leishmania major; intradermal; subcutaneous; immunity; disease outcome;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Sacks DL, Melby PC. Animal models for the analysis of immune responses to leishmaniasis. In Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W eds, Current Protocols in Immunology, Vol 4. New York, USA. John Wiley & Sons. 1998, p 19.2.1-19.2.20.
2 Combadiere B, Liard C. Transcutaneous and intradermal vaccination. Hum Vaccin 2011; 7: 811-827.   DOI   ScienceOn
3 Kautz-Neu K, Noordegraaf M, Dinges S, Bennett CL, John D, Clausen BE, von Stebut E. Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 2011; 208: 885-891.   DOI   ScienceOn
4 Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, Clausen BE. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169: 569-576.   DOI   ScienceOn
5 Kirkpatrick CE, Nolan TJ, Farrell JP. Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation. Parasitology 1987; 94: 451-465.   DOI
6 Baldwin TM, Elso C, Curtis J, Buckingham L, Handman E. The Site of Leishmania major infection determines disease severity and immune responses. Infect Immun 2003; 71: 6830-6834.   DOI
7 World Health Organization. Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, WHO Technical Report Series, No. 949. Geneva, Switzerland. 2010.
8 Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 2: 845-858.   DOI   ScienceOn
9 Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D. Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. Korean J Parasitol 2007; 45: 247-253.   DOI   ScienceOn
10 Lira R, Méndez S, Carrera L, Jaffe C, Neva F, Sacks D. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol 1998; 89: 331-342.   DOI   ScienceOn
11 Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D. Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice. Korean J Parasitol 2007; 45: 103-109.   DOI   ScienceOn
12 Tabbara KS, Peters NC, Afrin F, Mendez S, Bertholet S, Belkaid Y, Sacks DL. Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infect Immun 2005; 73: 4714-4722.   DOI   ScienceOn
13 Constant SL, Lee KS, Bottomly K. Site of antigen delivery can influence T-cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol 2000; 30: 840-847.   DOI   ScienceOn
14 Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V. Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res 2008; 103: 1413-1419.   DOI
15 Mendez S, Belkaid Y, Seder RA, Sacks D. Optimization of DNA vaccination against cutaneous leishmaniasis. Vaccine 2002; 20: 3702-3708.   DOI   ScienceOn
16 Bhowmick S, Mazumdar T, Ali N. Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection. Infect Immun 2009; 77: 1514-1523.   DOI   ScienceOn
17 Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, Ribeiro J, Sacks DL. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 1998; 188: 1941-1953.   DOI
18 Mahmoudzadeh-Niknam H, Abrishami F, Doroudian M, Moradi M, Alimohammadian MH, Parvizi P, Hatam GR, Mohebali M, Khalaj V. The problem of mixing up of Leishmania isolates in the laboratory: suggestion of ITS1 gene sequencing for verification of species. Iran J Parasitol 2011; 6: 41-48.
19 Cubas R, Zhang S, Kwon S, Sevick-Muraca EM, Li M, Chen C, Yao Q. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother 2009; 32: 118-128.   DOI
20 Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D. Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice. Exp Parasitol 2011; 127: 448-453.   DOI   ScienceOn
21 Mahmoudzadeh-Niknam H. Induction of partial protection against Leishmania major in BALB/c mice by Leishmania tropica. Scand J Lab Anim Sci 2004; 31: 201-207.
22 Mohanan D, Slütter B, Henriksen-Lacey M, Jiskoot W, Bouwstra JA, Perrie Y, Kündig TM, Gander B, Johansen P. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. J Control Release 2010; 147: 342-349.   DOI   ScienceOn